World Journal of Gastrointestinal Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Zhao JL, Wang MY, Lv YZ, Zhou YJ. Prognostic value of inflammatory markers in predicting recurrence-free survival in gastrointestinal stromal tumor patients: A nomogram-based approach. World J Gastrointest Oncol 2025; 17(2): 94956 [PMID: 39958548 DOI: 10.4251/wjgo.v17.i2.94956]
URL:	https://www.wjgnet.com/1948-5204/full/v17/i2/94956.htm

(106) (109) (0) (0) (0) (3) (2564) (5)

Number	Citing Articles
1	Xincheng Su, Jinhu Chen, Zhiming Cai, Lv Lin, Zhenrong Yang, Tao Lin, Weibin Song, Xinyu Chen, Zihan Lin, Yongjian Zhou. Study on risk stratification and treatment strategy of blood indicators in patients with moderate risk of GIST. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1742064
2	Yingzheng Ren, Fuyang Deng, Xiangge Guo, Yafei Fan, Yang Yang, Yuzhu Jin, Wei Sun, Kai Luo, Zhangxu Liu, Hao Wang, Qian Cao, Jia Hou, Shengze Li, Jinjun Wang, Yonghong Dong, Guixin Zhang. Preoperative Prediction of High Mitotic Count in Gastrointestinal Stromal Tumors Using CT Features and Serologic Indicators: An Interpretable Model with Multicenter External Validation. Journal of Inflammation Research 2026; doi: 10.2147/JIR.S593404
3	Yue-Fang Sun, Xuan-Ke Cao, Qing Wei, Yao-Hui Gao. Potential biomarkers for the prognosis of gastrointestinal stromal tumors. World Journal of Gastrointestinal Oncology 2025; 17(4): 102831 doi: 10.4251/wjgo.v17.i4.102831 Abstract(414) \| Core Tip(428) \| Full Article(HTML)(1399) \| Full Article (PDF)-423K(101) \| Full Article with Cover (PDF)-759K(178) \| Full Article (XML)-59K(103) \| Audio-882K(16) \| Peer-Review Report-273K(85) \| Answering Reviewers-130K(91) \| Times Cited (2) \| Total Visits (2390) \| Open
4	Zhiming Cai, Zhengnan Xu, Huimei Lin, Huibin Liu, Zihan Lin, Jinhu Chen, Shichai Hong, Weibin Song, Xinyu Chen, Yanchang Xu, Zhenrong Yang, Yongjian Zhou. Prognostic inflammatory–immune score-based risk stratification optimizes adjuvant therapy for non-gastric gastrointestinal stromal tumors: a multicenter study. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1846854
5	Shashank Kumar. Nomogram-based strategy to predict relapse-free survival in patients with gastrointestinal stromal tumor using inflammatory indicators. World Journal of Gastrointestinal Oncology 2025; 17(5): 103127 doi: 10.4251/wjgo.v17.i5.103127 Abstract(311) \| Core Tip(323) \| Full Article(HTML)(748) \| Full Article (PDF)-340K(88) \| Full Article with Cover (PDF)-574K(107) \| Full Article (XML)-25K(73) \| Audio-1334K(6) \| Peer-Review Report-246K(70) \| Answering Reviewers-125K(67) \| Times Cited (0) \| Total Visits (1016) \| Open
6	Chris B Lamprecht, Tyler Kashuv, Brandon Lucke-Wold. Utility of inflammatory markers as predictors of recurrence in gastrointestinal stromal tumors: Insights from a nomogram-based approach. World Journal of Gastrointestinal Oncology 2025; 17(9): 103702 doi: 10.4251/wjgo.v17.i9.103702 Abstract(89) \| Core Tip(93) \| Full Article(HTML)(396) \| Full Article (PDF)-385K(67) \| Full Article with Cover (PDF)-714K(80) \| Full Article (XML)-66K(42) \| Audio-757K(9) \| Peer-Review Report-171K(29) \| Answering Reviewers-102K(29) \| Times Cited (0) \| Total Visits (585) \| Open

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.